Hansoh Pharma
FDA Approved Drugs

Hansoh Pharma

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX Unclassified Discontinued
  • Total Records 17
  • Latest Approval Date Jun 28, 2023
  • Data Source FDA
  • First Approval Date Sep 26, 2012
All
17
View
Unclassified
2
View
Discontinued
3
View
RX
12
View
Company Overview

Company

Hansoh Pharma

Country

China

Website

Visit Website

Email

hansoh@hansoh.cn

Social Profiles

Company Snapshot

Hansoh Pharma

No.9, Dongjin Road, Economic & Technical Development Zone

China

www.hspharm.com/ hansoh@hansoh.cn View on Map
FDA Approved Drug Records ( 17 records )
2023
28 Jun
RX Application: 215905

Drug Name

AZACITIDINE

Product Number

1

Dosage Form

-

Strength

100MG/VIAL

Approval Date

2023-06-28

215905 / 1

Active Ingredient

AZACITIDINE

Application Number

215905

Product Number

1

Dosage Form

-

Strength

100MG/VIAL

Approval Date

2023-06-28

Regulatory Status

RX

2022
26 Jul
RX Application: 215011

Drug Name

BORTEZOMIB

Product Number

1

Dosage Form

-

Strength

3.5MG/VIAL

Approval Date

2022-07-26

215011 / 1

Active Ingredient

BORTEZOMIB

Application Number

215011

Product Number

1

Dosage Form

-

Strength

3.5MG/VIAL

Approval Date

2022-07-26

Regulatory Status

RX

-
Unclassified Application: 216119

Drug Name

DAPAGLIFLOZIN

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

-

216119 / 1

Active Ingredient

DAPAGLIFLOZIN

Application Number

216119

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 216119

Drug Name

DAPAGLIFLOZIN

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

-

216119 / 2

Active Ingredient

DAPAGLIFLOZIN

Application Number

216119

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

-

Regulatory Status

Unclassified

2022
15 Apr
RX Application: 213472

Drug Name

DECITABINE

Product Number

1

Dosage Form

-

Strength

50MG/VIAL

Approval Date

2022-04-15

213472 / 1

Active Ingredient

DECITABINE

Application Number

213472

Product Number

1

Dosage Form

-

Strength

50MG/VIAL

Approval Date

2022-04-15

Regulatory Status

RX

2022
10 Feb
RX Application: 214682

Drug Name

FULVESTRANT

Product Number

1

Dosage Form

-

Strength

250MG/5ML (50MG/ML)

Approval Date

2022-02-10

214682 / 1

Active Ingredient

FULVESTRANT

Application Number

214682

Product Number

1

Dosage Form

-

Strength

250MG/5ML (50MG/ML)

Approval Date

2022-02-10

Regulatory Status

RX

2013
07 May
RX Application: 202485

Drug Name

GEMCITABINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 200MG BASE/VIAL

Approval Date

2013-05-07

202485 / 1

Active Ingredient

GEMCITABINE HYDROCHLORIDE

Application Number

202485

Product Number

1

Dosage Form

-

Strength

EQ 200MG BASE/VIAL

Approval Date

2013-05-07

Regulatory Status

RX

2013
07 May
RX Application: 202485

Drug Name

GEMCITABINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2013-05-07

202485 / 2

Active Ingredient

GEMCITABINE HYDROCHLORIDE

Application Number

202485

Product Number

2

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2013-05-07

Regulatory Status

RX

2020
09 Mar
RX Application: 211021

Drug Name

ICATIBANT ACETATE

Product Number

1

Dosage Form

-

Strength

EQ 30MG BASE/3ML (EQ 10MG BASE/ML)

Approval Date

2020-03-09

211021 / 1

Active Ingredient

ICATIBANT ACETATE

Application Number

211021

Product Number

1

Dosage Form

-

Strength

EQ 30MG BASE/3ML (EQ 10MG BASE/ML)

Approval Date

2020-03-09

Regulatory Status

RX

2021
09 Jul
RX Application: 213363

Drug Name

MICAFUNGIN SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 50MG BASE/VIAL

Approval Date

2021-07-09

213363 / 1

Active Ingredient

MICAFUNGIN SODIUM

Application Number

213363

Product Number

1

Dosage Form

-

Strength

EQ 50MG BASE/VIAL

Approval Date

2021-07-09

Regulatory Status

RX

2021
09 Jul
RX Application: 213363

Drug Name

MICAFUNGIN SODIUM

Product Number

2

Dosage Form

-

Strength

EQ 100MG BASE/VIAL

Approval Date

2021-07-09

213363 / 2

Active Ingredient

MICAFUNGIN SODIUM

Application Number

213363

Product Number

2

Dosage Form

-

Strength

EQ 100MG BASE/VIAL

Approval Date

2021-07-09

Regulatory Status

RX

2018
24 Sep
Discontinued Application: 209399

Drug Name

OLANZAPINE

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2018-09-24

209399 / 1

Active Ingredient

OLANZAPINE

Application Number

209399

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2018-09-24

Regulatory Status

Discontinued

2018
24 Sep
Discontinued Application: 209399

Drug Name

OLANZAPINE

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2018-09-24

209399 / 2

Active Ingredient

OLANZAPINE

Application Number

209399

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2018-09-24

Regulatory Status

Discontinued

2018
24 Sep
Discontinued Application: 209399

Drug Name

OLANZAPINE

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2018-09-24

209399 / 3

Active Ingredient

OLANZAPINE

Application Number

209399

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2018-09-24

Regulatory Status

Discontinued

2022
25 May
RX Application: 208696

Drug Name

PEMETREXED DISODIUM

Product Number

1

Dosage Form

-

Strength

EQ 100MG BASE/VIAL

Approval Date

2022-05-25

208696 / 1

Active Ingredient

PEMETREXED DISODIUM

Application Number

208696

Product Number

1

Dosage Form

-

Strength

EQ 100MG BASE/VIAL

Approval Date

2022-05-25

Regulatory Status

RX

2022
25 May
RX Application: 208696

Drug Name

PEMETREXED DISODIUM

Product Number

2

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2022-05-25

208696 / 2

Active Ingredient

PEMETREXED DISODIUM

Application Number

208696

Product Number

2

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2022-05-25

Regulatory Status

RX

2012
26 Sep
RX Application: 91106

Drug Name

VINORELBINE TARTRATE

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE/ML

Approval Date

2012-09-26

91106 / 1

Active Ingredient

VINORELBINE TARTRATE

Application Number

91106

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE/ML

Approval Date

2012-09-26

Regulatory Status

RX

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    4 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    17 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
17 total
  • RX
  • Unclassified
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

AZACITIDINE

Application Number

215905

Product Number

1

Active Ingredient

AZACITIDINE

Dosage Form

-

Strength

100MG/VIAL

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit